Company / Accounts Receivable
Nutex Health, Inc. Accounts Receivable History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$232.4M
FY2024
5-year range
$57.8M / $232.4M
FY2020-FY2024
Trend
+296.7%
vs FY2023
Sector context
#165 of 276
Industrials
What the data says
Accounts Receivable changed +297% YoY in FY2024, a notable deviation from the 7-year average annual change of +88526%.
Based on SEC 10-K filings.
$232M in FY2024 with a 5-year CAGR of +371.1%.
Improved from $58M to $232M over the past 2 years.
Industrials sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +27.3%
- 5-Year CAGR
- +371.1%
- 10-Year CAGR
- -
Sector benchmark
#165 of 276 in IndustrialsTop 60% of 276This company $232.4M Sector average $852.0M
▼
-72.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +371.1%, indicating consistent growth.
- In FY2024, accounts receivable increased 296.7% year-over-year.
- Ranks #165 out of 276 companies in the Industrials sector.
- Lowest accounts receivable in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 40.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $232.4M | +296.7% |
| FY2023 | $58.6M | +1.4% |
| FY2022 | $57.8M | -48.8% |
| FY2021 | $112.8M | +616682.3% |
| FY2020 | $18.3K | -81.8% |
| FY2019 | $100.2K | -46.2% |
| FY2018 | $186.2K | +2876.5% |
| FY2017 | $6.3K | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026